Back to companies
EPISYS SCIENCE INC
Seed / Series Adefense-other · Series A
Seed Signal Score
14/25
Team Strength
2/5
Validation Depth
4/5
Novelty
2/5
Market Timing
4/5
Capital Efficiency
2/5
Funding
$12.4M
Total raised
$12.4M
Last round · December 13, 2024
Description
STRATFI SBIR Sequential Phase II
Validation Signals
SBIR Phase II
Score Rationale
Episys has strong validation depth with confirmed STRATFI SBIR Phase II award and $12.4M in total funding, and solid market timing via active DoD modernization pull. However, team leadership is not named in available data, and at Series A with $12.4M deployed there is no evidence of shipped product or clear technical differentiation—raising concerns about capital efficiency and whether funding has translated to concrete output.